Black Rock Inc. Molecular Templates, Inc. Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.39 - $0.54 $58,937 - $81,605	-151,121 Reduced 20.19%	597,189 $286,000
Q1 2023 May 12, 2023	SELL	$0.33 - $0.58 $19,505 - $34,282	-59,107 Reduced 7.32%	748,310 $284,000
Q4 2022 Feb 13, 2023	SELL	$0.33 - $12.0 $110,559 - $4.02 Million	-335,030 Reduced 29.33%	807,417 $266,000
Q3 2022 Nov 14, 2022	SELL	$0.68 - $11.25 $10,296 - $170,347	-15,142 Reduced 1.31%	1,142,447 $856,000
Q2 2022 Aug 12, 2022	SELL	$0.81 - $3.43 $1.36 Million - $5.74 Million	-1,674,156 Reduced 59.12%	1,157,589 $1.06 Million
Q1 2022 May 12, 2022	SELL	$2.27 - $4.13 $43,484 - $79,114	-19,156 Reduced 0.67%	2,831,745 $9.77 Million
Q4 2021 Feb 10, 2022	BUY	$3.37 - $6.87 $769,441 - $1.57 Million	228,321 Added 8.71%	2,850,901 $11.2 Million
Q3 2021 Nov 09, 2021	SELL	$5.78 - $7.86 $181,052 - $246,206	-31,324 Reduced 1.18%	2,622,580 $17.6 Million
Q2 2021 Aug 11, 2021	BUY	$7.82 - $12.44 $20.8 Million - $33 Million	2,653,904 New	2,653,904 $20.8 Million

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.